Heart and Vessels

, Volume 29, Issue 1, pp 1–6 | Cite as

Efficacy and safety of low-dose clopidogrel in Japanese patients after drug-eluting stent implantation: a randomized pilot trial

  • Kenji Ohkubo
  • Yoshihide Fujimoto
  • Yo Iwata
  • Hideki Kitahara
  • Tadayuki Kadohira
  • Kazumasa Sugimoto
  • Tomoki Morino
  • Yoshio Kobayashi
Original Article

Abstract

In Japan, a lower maintenance dose of ticlopidine is used than in the United States and Europe. Therefore a lower maintenance dose of clopidogrel may also be considered appropriate in Japanese patients. The present randomized pilot study evaluated the efficacy and safety of 50 mg clopidogrel in Japanese patients who underwent drug-eluting stent (DES) implantation. A total of 200 patients with 277 lesions who underwent intravascular ultrasound-guided DES implantation were enrolled. The subjects were allocated to the 50- or 75-mg clopidogrel group. All patients received 100 mg aspirin daily before the procedure, and this continued indefinitely. The duration of clinical follow-up was 21.8 ± 5.7 months in the 75-mg group and 21.9 ± 6.1 months in the 50-mg group (P = 0.96). During follow-up, no cardiac death, myocardial infarction, or stent thrombosis was observed in either group. Side effects of clopidogrel were observed in 4 patients (4.0 %) in the 75-mg group and in 4 patients (4.0 %) in the 50-mg group. Following this randomized pilot study, it may be justified to perform a large-scale randomized study comparing 50- and 75-mg dosing of clopidogrel in Japanese patients undergoing coronary stent implantation.

Keywords

Antiplatelet therapy Stent Stent thrombosis 

References

  1. 1.
    Fukushima K, Kobayashi Y, Okuno T, Nakamura Y, Sakakibara M, Nakayama T, Kuroda N, Miyazaki A, Shimizu Y, Komuro I (2007) Incidence of side-effects of ticlopidine after sirolimus-eluting stent implantation. Circ J 71:617–619PubMedCrossRefGoogle Scholar
  2. 2.
    Kitahara J, Kobayashi Y, Fujimoto Y, Nakamura Y, Nakayama T, Kuroda N, Himi T, Miyazaki A, Komuro I (2007) Late stent thrombosis in patients receiving ticlopidine and aspirin after sirolimus-eluting stent implantation. Circ J 72:168–169CrossRefGoogle Scholar
  3. 3.
    Nakayama A, Morita H, Ando J, Fujita H, Ohtsu H, Nagai R (2012) Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention. Heart Vessels. doi: 10.1007/s00380-012-0248-3 Google Scholar
  4. 4.
    Miyai N, Kinoshita N, Oota K, Yamada T, Nakamura R, Irie H, Hashimoto T, Tamaki S, Matsubara H (2011) Long-term angiographic outcomes of post-sirolimus-eluting stent restenosis in Japanese patients. Heart Vessels 26:168–175PubMedCrossRefGoogle Scholar
  5. 5.
    Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JP Jr, Cauhan MS, Rodriguez O, Kuntz RE (2001) Stent thrombosis in the modern era. A pooled analysis of multicenter coronary stent clinical trials. Circulation 103:1967–1971PubMedCrossRefGoogle Scholar
  6. 6.
    Moussa I, Oetgen M, Roubin G, Colombo A, Wang X, Iyer S, Maida R, Collins M, Kreps E, Moses JW (1999) Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 99:2364–2366PubMedCrossRefGoogle Scholar
  7. 7.
    Fukushima K, Kobayashi Y, Kitahara H, Iwata Y, Kuroda N, Ooyama M, Kuwabara Y, Nomura F, Komuro I (2010) Antiplatelet effect of 50 mg maintenance dose of clopidogrel compared to 200 mg ticlopidine: a preliminary study. Heart Vessels 25:1–41CrossRefGoogle Scholar
  8. 8.
    Ohkubo K, Kobayashi Y (2011) Long-term safety and efficacy of low-dose clopidogrel in Japanese patients undergoing coronary stenting. Cardiovasc Interv Ther 26:104–108PubMedCrossRefGoogle Scholar
  9. 9.
    Asano T, Kobayashi Y, Fukushima K, Iwata Y, Kitahara H, Ishio N, Kuroda N, Komuro I (2008) Safety and efficacy of low-dose clopidogrel in Japanese patients undergoing coronary stenting: preliminary 30-day clinical outcome. Circ J 72:1707–1708PubMedCrossRefGoogle Scholar
  10. 10.
    Colombo A, Orlic D, Stankovic G, Corvaja M, Spanos V, Montorfano M, Liistro F, Carlino M, Airoldi F, Chieffo A, Di Mario C (2003) Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 107:2178–2180PubMedCrossRefGoogle Scholar
  11. 11.
    Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694PubMedCrossRefGoogle Scholar
  12. 12.
    Mauri L, Hsieh WH, Massaro JM, Ho KK, D’Agostio R, Cutlip DE (2007) Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356:1020–1029PubMedCrossRefGoogle Scholar
  13. 13.
    Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, Iwamoto K, Tajiri M, J-ROCKET AF Study Investigators (2012) Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation—the J-ROCKET AF study. Circ J 76:2104–2111PubMedCrossRefGoogle Scholar
  14. 14.
    Ohkubo K, Kobayashi Y, Nakamura Y, Miyazaki A (2011) Incidence of side effects of dual antiplatelet therapy with clopidogrel and aspirin after coronary stent implantation. Cardiovasc Interv Ther 26:33–37PubMedCrossRefGoogle Scholar
  15. 15.
    Fujii K, Carlier SG, Mintz GS, Yand YM, Moussa I, Weisz G, Dangas G, Mahran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB (2005) Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45:995–998PubMedCrossRefGoogle Scholar
  16. 16.
    Biondi-Zoccai GG, Agostoni P, Sangiorgi GM, Arioldi F, Cosgrave J, Chieffo A, Barbagallo R, Tamburino C, Vittori G, Falchetti E, Margheri M, Briguori C, Remigi E, Iakovou I, Colombo A, Real-world Eluting-stent Comparative Italian retrospective Evaluation Study Investigators (2006) Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation. Eur Heart J 27:540–546PubMedCrossRefGoogle Scholar
  17. 17.
    Moreno R, Fernández C, Hernández R, Alfonso F, Angiolillo DJ, Sabaté M, Escaned J, Bañuelos C, Fernández-Ortiz A, Macaya C (2005) Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45:954–959PubMedCrossRefGoogle Scholar
  18. 18.
    Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Weissman NJ, Lindsay J, Waksman R (2008) The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 29:1851–1857PubMedCrossRefGoogle Scholar
  19. 19.
    Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP, COGENT Investigators (2010) Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 363:1909–1917PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2012

Authors and Affiliations

  • Kenji Ohkubo
    • 1
  • Yoshihide Fujimoto
    • 1
  • Yo Iwata
    • 1
  • Hideki Kitahara
    • 1
  • Tadayuki Kadohira
    • 1
  • Kazumasa Sugimoto
    • 1
  • Tomoki Morino
    • 1
  • Yoshio Kobayashi
    • 1
  1. 1.Department of Cardiovascular MedicineChiba University Graduate School of MedicineChibaJapan

Personalised recommendations